Varonis Systems (VRNS) used Citi’s 2026 Global TMT Conference on September 9 to outline the results of its multi-year transition to a SaaS-delivery model and the role artificial intelligence is playing in its expanding product line.
Senior Vice President of Strategic Programs David Gibson and Chief Financial Officer and Chief Operating Officer Guy Melamed spoke to analysts about progress since the company announced its shift to SaaS at the beginning of 2023, with an end-of-2024 deadline for retiring its on-premises subscription offering.
Management said the SaaS version of its platform is “orders of magnitude better” than the prior on-premises product. Gibson noted the transition eliminated sales-productivity drags associated with conversion documentation, procurement reviews, legal negotiations and SaaS security checklists.
In a move to simplify sales and procurement, Varonis also reduced its product lineup from 43 separate SKUs to a bundled offering.
On the AI front, the company highlighted its acquisition of Atlas, which it closed in the first quarter of 2026, as a central pillar of its strategy. Atlas provides AI-security capabilities designed to identify AI systems, assess risk, detect misbehavior and monitor interactions with sensitive data. Melamed said Atlas came up in nearly every customer conversation during the second quarter.
Executives pointed to a changing threat landscape in which users no longer need malicious intent to expose sensitive data. Querying a chatbot with weak access controls can leak confidential information within seconds, they said.
Varonis also referenced its completed acquisition of Cyral last year, which entered the database-activity-monitoring (DAM) market. Management said the DAM segment represents roughly $1 billion in annual recurring revenue today, concentrated among two vendors and several hundred customers.
The company cited full-year 2024 SaaS ARR growth guidance of 28% to 33%, excluding conversion-related growth. It stated a long-term ambition to reach $1 billion in ARR, with growth expected to sustain above 20% in subsequent years.
Shares delivered an 87% return over the past six months and a 39% gain year to date, closing around $46.09. The stock carried a trailing twelve-month loss of $1.22 per share; analysts forecast a turnaround to profitability this year with earnings of $0.17 per share.
Regarding the federal market, Varonis holds FedRAMP Moderate certification but acknowledged it has not yet made significant inroads there. Management said low expectations for federal revenue have been built into guidance, and the company has not prioritized pursuing FedRAMP High certification.
In late Q2, press speculation about a potential change of control created near-term market noise and contributed to deal slippage. A portion of affected deals recovered before the quarter ended, and the remainder were expected to close in Q3.
